Abstract
Gold(I) mediated Meyer Schuster rearrangement for the installation of the 'lower' side chain of prostaglandins and their analogs has been developed. This Au-mediated rearrangement, featuring a low catalyst loading and mild reaction conditions, has been demonstrated to be an efficient alternative to the standard Horner-Wadsworth-Emmons reaction in prostaglandin chemistry. Moreover, the present results provide a new synthetic process leading to pharmacologically active prostanoids: Latanoprost and Bimatoprost, that continue to hold key positions in the anti-glaucoma drug market. (C) 2010 Elsevier Ltd. All rights reserved.
| Original language | English |
|---|---|
| Pages (from-to) | 7472-7478 |
| Number of pages | 7 |
| Journal | Tetrahedron |
| Volume | 66 |
| Issue number | 38 |
| DOIs | |
| Publication status | Published - 18 Sept 2010 |
Keywords
- Anti-glaucoma drug
- Meyer-Schuster rearrangement
- Gold Chemistry
- Prostanoids syntheses
- Total synthesis
- GOLD
- KETONES
- CATALYSIS
Fingerprint
Dive into the research topics of 'The Meyer-Schuster rearrangement: a new synthetic strategy leading to prostaglandins and their drug analogs, Bimatoprost and Latanoprost'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver